CRA provided testimony in support of Masimo in its successful effort to refute monopolization, tying, and other antitrust counterclaims following a competitor’s infringement of its medical device patents. The team was led by Tim Snail and included Sharon Pang, Eyal Dvir, Omeed Alerasool, Ryne Belliston, Carl Hayden, Daniel Ladd, Joseph Marin, Flore Nouvel, and Sarah Black.
Residual doubts: Carving up common impact in the turkey class certification decision
In the article, “Residual Doubts: Carving Up Common Impact in the Turkey Class Certification Decision,” published by the American Bar Association (ABA), CRA’s...